← SynDRA
THIOPERAMIDE
SynDRA canonical compound SYN0008950 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | HRH4 |
|---|
| Mechanism of action | Histamine receptor antagonist |
|---|
All known targets
Mechanisms of action (all sources)
- Histamine receptor antagonist
- HRH3 ANTAGONIST
- HRH4 ANTAGONIST
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ADRA2A
- CYP3A4
- ADRA2C
- CYP46A1
- ARSA
- BACE1
- THPO
- SAMHD1
- PTH1R
- NFKB1
- HRH2
- HRH1
- HDAC6
- GMNN
- GBA1
- EHMT2
- ALDH1A1
- ALOX15B
- CYP2D6
- CYP2C9
- CYP2C19
- CYP1A2
- CBX1
- TRPV1
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- CP1A2
- CP2C9
- CP2CJ
- CP2D6
- CP3A4
Drug classes
- Anticonvulsants
- Histamine H3 Antagonists
Cross-references
Synonyms
- Thioperamide maleate
- MR 12842
- UNII-II4319BWUI
- 1-Piperidinecarbothioamide, N-cyclohexyl-4-(1H-imidazol-4-yl)-
- II4319BWUI
- N-Cyclohexy-4-(imidazol-4-yl)-1-piperidinecarbothioamide
- CHEMBL260374
- N-cyclohexyl-4-(1H-imidazol-5-yl)piperidine-1-carbothioamide
- CHEBI:81391
- N-Cyclohexyl-4-(1H-imidazol-5-yl)-1-piperidinecarbothioamide
- Tocris-0644
- Lopac-T-123
- Lopac0_001214
- SCHEMBL2235762
- GTPL1267
- AC1MI071
- BDBM22914
- DTXSID50147555
- MolPort-023-275-907
- MolPort-015-163-994
- N-cyclohexyl-4-(3H-imidazol-4-yl)piperidine-1-carbothioamide
- RefChem:189594
- DTXCID3070046
- QKDDJDBFONZGBW-UHFFFAOYSA-N
- N-cyclohexyl-4-(1H-imidazol-4-yl)piperidine-1-carbothioamide
- orb1703979
- SCHEMBL4900899
- HMS3411M08
- HMS3675M08
- EX-A14363
- AKOS024458593
- AKOS030228083
- CCG-205288
- SDCCGSBI-0051181.P002
- NCGC00015988-01
- NCGC00015988-02
- NCGC00015988-03
Look up THIOPERAMIDE in the interactive SynDRA portal →